Estabrook Capital Management’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-7
| Closed | -$54 | – | 359 |
|
|
2018
Q2 | $54 | Hold |
7
| – | – | ﹤0.01% | 358 |
|
|
2018
Q1 | $252 | Hold |
7
| – | – | ﹤0.01% | 362 |
|
|
2017
Q4 | $307 | Hold |
7
| – | – | ﹤0.01% | 366 |
|
|
2017
Q3 | $309 | Hold |
7
| – | – | ﹤0.01% | 387 |
|
|
2017
Q2 | $267 | Hold |
7
| – | – | ﹤0.01% | 389 |
|
|
2017
Q1 | $390 | Hold |
7
| – | – | ﹤0.01% | 393 |
|
|
2016
Q4 | $382 | Hold |
7
| – | – | ﹤0.01% | 433 |
|
|
2016
Q3 | $436 | Hold |
7
| – | – | ﹤0.01% | 402 |
|
|
2016
Q2 | $474 | Hold |
7
| – | – | ﹤0.01% | 416 |
|
|
2016
Q1 | $408 | Hold |
7
| – | – | ﹤0.01% | 426 |
|
|
2015
Q4 | $1.69K | Hold |
7
| – | – | ﹤0.01% | 417 |
|
|
2015
Q3 | $1.14K | Hold |
7
| – | – | ﹤0.01% | 433 |
|
|
2015
Q2 | $2.72K | Hold |
7
| – | – | ﹤0.01% | 404 |
|
|
2015
Q1 | $3.01K | Hold |
7
| – | – | ﹤0.01% | 414 |
|
|
2014
Q4 | $1.97K | Hold |
7
| – | – | ﹤0.01% | 427 |
|
|
2014
Q3 | $1.4K | Hold |
7
| – | – | ﹤0.01% | 436 |
|
|
2014
Q2 | $1.76K | Hold |
7
| – | – | ﹤0.01% | 435 |
|
|
2014
Q1 | $1.91K | Hold |
7
| – | – | ﹤0.01% | 435 |
|
|
2013
Q4 | $2.62K | Hold |
7
| – | – | ﹤0.01% | 427 |
|
|
2013
Q3 | $3.83K | Hold |
7
| – | – | ﹤0.01% | 425 |
|
|
2013
Q2 | $1.69K | Buy |
+7
| New | +$1.69K | ﹤0.01% | 442 |
|